Inspire Medical Systems Inc (INSP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.77 is considered Undervalued compared with the five-year average of 11.56. The fair price of Inspire Medical Systems Inc (INSP) is between 118.42 to 381.85 according to relative valuation method. Compared to the current price of 64.81 USD , Inspire Medical Systems Inc By Undervalued By 45.27%.

Relative Value

Fair Zone

118.42-381.85

Current Price：64.81

45.27%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Inspire Medical Systems Inc (INSP) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Inspire Medical Systems Inc (INSP) has a current Price-to-Book (P/B) ratio of 4.02. Compared to its 3-year average P/B ratio of 9.12, the current P/B ratio is approximately -55.88% higher. Relative to its 5-year average P/B ratio of 15.13, the current P/B ratio is about -73.41% higher. Inspire Medical Systems Inc (INSP) has a Forward Free Cash Flow (FCF) yield of approximately 3.69%. Compared to its 3-year average FCF yield of 0.96%, the current FCF yield is approximately 283.23% lower. Relative to its 5-year average FCF yield of 0.35%, the current FCF yield is about 943.35% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for INSP competitors is 6.53, providing a benchmark for relative valuation. Inspire Medical Systems Inc Corp (INSP.N) exhibits a P/S ratio of 2.77, which is -57.56% above the industry average. Given its robust revenue growth of 12.25%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of INSP increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of INSP in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is INSP currently overvalued or undervalued?

Inspire Medical Systems Inc (INSP) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.77 is considered Undervalued compared with the five-year average of 11.56. The fair price of Inspire Medical Systems Inc (INSP) is between 118.42 to 381.85 according to relative valuation method. Compared to the current price of 64.81 USD, Inspire Medical Systems Inc is Undervalued By 45.27%.

What is Inspire Medical Systems Inc (INSP) fair value?

INSP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Inspire Medical Systems Inc (INSP) is between 118.42 to 381.85 according to relative valuation method.

How does INSP's valuation metrics compare to the industry average?

The average P/S ratio for INSP's competitors is 6.53, providing a benchmark for relative valuation. Inspire Medical Systems Inc Corp (INSP) exhibits a P/S ratio of 2.77, which is -57.56% above the industry average. Given its robust revenue growth of 12.25%, this premium appears unsustainable.

What is the current P/B ratio for Inspire Medical Systems Inc (INSP) as of Mar 03 2026?

As of Mar 03 2026, Inspire Medical Systems Inc (INSP) has a P/B ratio of 4.02. This indicates that the market values INSP at 4.02 times its book value.

What is the current FCF Yield for Inspire Medical Systems Inc (INSP) as of Mar 03 2026?

As of Mar 03 2026, Inspire Medical Systems Inc (INSP) has a FCF Yield of 3.69%. This means that for every dollar of Inspire Medical Systems Inc's market capitalization, the company generates 3.69 cents in free cash flow.

What is the current Forward P/E ratio for Inspire Medical Systems Inc (INSP) as of Mar 03 2026?

As of Mar 03 2026, Inspire Medical Systems Inc (INSP) has a Forward P/E ratio of 58.01. This means the market is willing to pay $58.01 for every dollar of Inspire Medical Systems Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Inspire Medical Systems Inc (INSP) as of Mar 03 2026?

As of Mar 03 2026, Inspire Medical Systems Inc (INSP) has a Forward P/S ratio of 2.77. This means the market is valuing INSP at $2.77 for every dollar of expected revenue over the next 12 months.

INSP Valuation